616
Participants
Start Date
March 12, 2014
Primary Completion Date
March 23, 2018
Study Completion Date
November 6, 2019
Roxadustat
Oral tablet.
Darbepoetin alfa
Subcutaneous or intravenous injection.
Site GE99503, Tbilisi
Site GE99504, Tbilisi
Site GE99502, Tbilisi
Site FI35810, Helsinki
Site MK38901, Skopje
Site HU36028, Budapest
Site BG35907, Sofia
Site BG35927, Sofia
Site SI38603, Maribor
Site HU36027, Kistarcsa
Site UA38017, Kiev
Site SI38609, Šempeter pri Gorici
Site MK38903, Struga
Site UA38008, Odesa
Site BG35916, Varna
Site HR38502, Zagreb
Site HR38509, Zagreb
Site RO40012, Bucharest
Site RS38102, Belgrade
Site RS38105, Belgrade
Site RS38101, Niš
Site RS38103, Belgrade
Site RO40003, Bucharest
Site ES34039, Córdoba
Site ES34049, Ferrol
Site ES34041, Santiago de Compostela
Site ES34054, Girona
Site UA38021, Cherkasy
Site RO40021, Bucharest
Site ES34017, Jaén
Site DE49065, Hamburg
Site ES34037, Madrid
Site ES34030, Majadahonda
Site ES34010, Madrid
Site IL97215, Haifa
Site HR38504, Slavonski Brod
Site RS38117, Kruševac
Site DE49054, Düsseldorf
Site FR33007, Saint-Priest-en-Jarez
Site UA38001, Ternopil
Site CZ42008, Liberec
Site HR38505, Karlovac
Site UA38006, Dnipropetrovsk
Site DE49073, Cloppenburg
Site UA38011, Kharkiv
Site FR33009, Colmar
Site FR33012, Lyon
Site IL97202, Be’er Ya‘aqov
Site DE49075, Heilbronn
Site UA38016, Ivano-Frankivsk
Site UA38009, Lviv
Site ME38201, Podgorica
Site ME38202, Nikšić
Site FR33004, Avignon
Site FR33062, Limoges
Site UA38018, Uzhhorod
Site RU70047, Moscow
Site RU70006, Moscow
Site RU70057, Yaroslavl
Site RU70001, Yaroslavl
Site RU70011, Saint Petersburg
Site RU70002, Saint Petersburg
Site BY37502, Vitebsk
Site BY37506, Minsk
Site BY37507, Minsk
Site BY37505, Minsk
Site BY37503, Brest
Site BY37501, Grodno
Site RU70014, Rostov-on-Don
Site RU70060, Saratov
Site RO40004, Oradea
Site RU70024, Chelyabinsk
Site RU70003, Nizhny Novgorod
Site RU70004, Omsk
Site RU70054, Irkutsk
Site AT43009, Vienna
Site CZ42021, Prague
Site FR33010, Grenoble
Site HU36029, Budapest
Site HU36046, Velence
Site IE35301, Cork
Site PL48009, Wroclaw
Site RS38104, Belgrade
Site UA38007, Mykolaiv
Site HR38510, Zagreb
Site CZ42018, Nový Jičín
Site DE49057, Hoyerswerda
Site HU36008, Pécs
Site LV37101, Riga
Site LV37104, Ventspils
Site NL31005, Utrecht
Site PL48001, Krakow
Site PL48066, Puławy
Site PL48013, Szczecin
Site PL48007, Tarnów
Site PL48004, Warsaw
Site PL48059, Zamość
Site PT35120, Almada
Site PT35131, Braga
Site PT35112, Carnaxide
Site PT35119, Evora
Site PT35118, Lisbon
Site PT35133, Matosinhos Municipality
Site PT35122, Setúbal
Site PT35132, Vila Nova de Gaia
Site SK42102, Košice
Site SK42109, Košice
Site SK42113, Púchov
Site SK42116, Senica
Site SI38615, Jesenice
Site SI38619, Slovenj Gradec
Site ES34026, Barcelona
Site GB44098, Dorchester
Site GB44064, Birmingham
Site GB44099, Dartford
Site GB44102, Kings Lynn
Site GB44081, Leicester
Site GB44086, London
Site GB44006, London
Site GB44082, London
Site GB44097, Nottingham
Site GB44100, Orpington
Site GB44101, Preston
Site GB44080, Stoke-on-Trent
Site GB44001, Swansea
Collaborators (1)
FibroGen
INDUSTRY
Astellas Pharma Europe B.V.
INDUSTRY